HedgeChatter

  • Home /
  • Tag Archives

XON

Results of General Meeting (PDF)

[at noodls] – 20 March 2014 AquaBounty Technologies (AquaBounty or the Company) Results of General Meeting Further to the announcement of 6 March 2014, the Board of AquaBounty Technologies, Inc. … moreView todays social media effects on XONView the latest stocks trending across Twitter. Click to view dashboardSee who Intrexon is hiring next, click here to view […]

March 21, 2014 Bystocknews , Comments Off on Results of General Meeting (PDF) read more

8:33 am Intrexon and Amneal Pharma form exclusive channel collaboration to develop an improved production process for a complex active pharmaceutical ingredient

moreView todays social media effects on XONView the latest stocks trending across Twitter. Click to view dashboardSee who Intrexon is hiring next, click here to view […]

March 11, 2014 Bystocknews , Comments Off on 8:33 am Intrexon and Amneal Pharma form exclusive channel collaboration to develop an improved production process for a complex active pharmaceutical ingredient read more

Proposed Fundraising and General Meeting (PDF)

[at noodls] – 6 March 2014 AquaBounty Technologies, Inc. … This is an abstract of the original noodl. To continue reading this document, click here for the original version. moreView todays social media effects on XONView the latest stocks trending across Twitter. Click to view dashboardSee who Intrexon is hiring next, click here to view […]

March 7, 2014 Bystocknews , Comments Off on Proposed Fundraising and General Meeting (PDF) read more

Soligenix Announces $300,000 NIAID SBIR Grant Award Supporting Further Evaluation of SGX943 as a Treatment for Melioidosis

[PR Newswire] – PRINCETON, N.J., Feb. 14, 2014 /PRNewswire/ — Soligenix, Inc. (SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unme moreView todays social media effects on XONView the latest stocks trending across Twitter. Click to view dashboardSee who Intrexon is hiring next, click here […]

February 14, 2014 Bystocknews , Comments Off on Soligenix Announces $300,000 NIAID SBIR Grant Award Supporting Further Evaluation of SGX943 as a Treatment for Melioidosis read more